Biological Effects of the Pim Kinase Inhibitor, SGI-1776, in Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2013.05.019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Combination of Pim Kinase Inhibitor SGI-1776 and Bendamustine in B-Cell Lymphoma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Targeting the Pim Kinases in Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2015English

Biological Determinants of Health Disparities in Multiple Myeloma

Blood Cancer Journal
OncologyHematology
2018English

Targeting the Phosphatidylinositol 3-Kinase Pathway in Multiple Myeloma

Clinical Cancer Research
Cancer ResearchOncology
2007English

Investigating Effects of Proteasome Inhibitor on Multiple Myeloma Cells Using Confocal Raman Microscopy

Sensors
InstrumentationInformation SystemsElectronic EngineeringBiochemistryAnalytical ChemistryMolecular Physics,ElectricalAtomicMedicineOptics
2016English

CHIR-258, a Novel, Multitargeted Tyrosine Kinase Inhibitor for the Potential Treatment of T(4;14) Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

Kinase Inhibitors as Potential Agents in the Treatment of Multiple Myeloma

Oncotarget
Oncology
2016English

Molecular Docking of Citronellol, Geraniol and Ester Derivatives as Pim 1 Kinase Inhibitor of Leukemia Cancer

Jurnal Kimia Valensi
2019English

Development of Biological Warfare Sensors Using SGI High Performance Computers

Computational Methods in Science and Technology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy